Choreo LLC’s Aspen Aerogels ASPN Stock Holding History

Choreo LLC’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,250	Closed	-$59K	–	1695
2026 Q1	$59K	Buy	17,250 +422	+3%	+$1.42K	﹤0.01%	1566
2025 Q4	$49.6K	Buy	+16,828	New	+$86.8K	﹤0.01%	1536

Other funds holding ASPN

KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Choreo LLC's ASPN Position: Q2 2026 in Review

Choreo LLC sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 17,250 shares — an estimated $59K sold.

Choreo LLC first reported a position in ASPN in Q4 2025 and held it in 2 quarters. The position peaked at $59K in Q1 2026. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

Choreo LLC reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
Choreo LLC sold 17,250 Aspen Aerogels shares in Q2 2026, an estimated $59K.
Choreo LLC first reported a position in Aspen Aerogels in Q4 2025 and held it in 2 quarters.
Choreo LLC's Aspen Aerogels position peaked at $59K in Q1 2026.
180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.